Different positions of BMS, Gilead and Abbvie over hepatitis C guideline
Disease guidelines are important to pharmaceutical companies. They can be even more important for recently-launched drugs.
This is why the industry has paid attention to the hepatitis C guideline which was recently announced at the Korean Association for the Study of the Liver’s(KASL) public hea...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
